Track the ADURO BIOTECH, INC. stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 11 January 2016 (Levée d'options). Among the most active insiders: ISAACS STEPHEN T. Every trade is accessible without an account.
22
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
13 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate ADURO BIOTECH, INC. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ADURO BIOTECH, INC. is a biopharmaceutical company focused on developing innovative treatments for cancer. The company is listed on NASDAQ under the ticker symbol ADRO.